lungcelltherapy.com
网站标题: TIL Therapy NSCLC Trial Now Enrolling *s | Iovance Biotherapeutics
网站简介: The LUN-202 clinical trial is enrolling *s living in North America who h*e been diagnosed with recurrent or metastatic non-small cell lung cancer. Learn more.
关键字: NSCLC  Metastatic  Non-Small  Cell  Lung  Cancer  Tumor  Infiltrating  Lymphocytes  TIL  

 

    1/1  [1] 

Copyright © 2014 Lehaigou Ltd. All Rights Reserved.
谷歌地图 百度地图 关于我们 联系我们